Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: a phase I, dose-finding study

This publication has 15 references indexed in Scilit:

• Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy
  Journal of Clinical Oncology, 1999
• A phase I study of docetaxel and 5-fluorouraciI in patients with advanced solid malignancies
  Annals of Oncology, 1999
• A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.
  British Journal of Cancer, 1998
• Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.
  Journal of Clinical Oncology, 1998
• Rapid and sensitive high-performance liquid chromatographic analysis of halogenopyrimidines in plasma
  Journal of Chromatography B: Biomedical Sciences and Applications, 1997
• A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC
  British Journal of Cancer, 1996
• Docetaxel (Taxotere®) a review of preclinical and clinical experience. Part I
  Anti-Cancer Drugs, 1995
• Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
  New England Journal of Medicine, 1994
• Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method
  Journal of Chromatography B: Biomedical Sciences and Applications, 1992
• No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion
  British Journal of Cancer, 1992